.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Federal Trade Commission
QuintilesIMS
McKinsey
Healthtrust
Cipla
Teva
Deloitte
Dow
Queensland Health

Generated: September 20, 2017

DrugPatentWatch Database Preview

Wyeth Ayerst Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Applicant: Wyeth Ayerst

Patents:0
Tradenames:64
Ingredients:56
NDAs:82
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
UNIPEN
nafcillin sodium
FOR SOLUTION;ORAL050199-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
SPARINE
promazine hydrochloride
TABLET;ORAL010348-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-006Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PHENERGAN
promethazine hydrochloride
INJECTABLE;INJECTION008857-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
NALOXONE
naloxone hydrochloride
INJECTABLE;INJECTION070190-001Sep 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
GRISACTIN
griseofulvin, microcrystalline
TABLET;ORAL060212-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
CYCLAPEN-W
cyclacillin
TABLET;ORAL050509-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
DIGOXIN
digoxin
INJECTABLE;INJECTION084386-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
INDERAL
propranolol hydrochloride
SUSPENSION;ORAL019536-001Dec 12, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
WYTENSIN
guanabenz acetate
TABLET;ORAL018587-001Sep 7, 1982► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-001Jul 31, 1987► Subscribe► Subscribe
Wyeth Ayerst
WYTENSIN
guanabenz acetate
TABLET;ORAL018587-003Sep 7, 1982► Subscribe► Subscribe
Wyeth Ayerst
PMB 400
estrogens, conjugated; meprobamate
TABLET;ORAL010971-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
INDERIDE LA 80/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-001Jul 3, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
US Department of Justice
Medtronic
Cerilliant
Daiichi Sankyo
Chinese Patent Office
Colorcon
Cipla
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot